Market Overview

UPDATE: Wedbush Downgrades Xylem on Multiple Negative Factors

Related XYL
How To Trade The Expected Expansion In U.S. Infrastructure Spending
Mother Nature Will Determine Future Of Portfolio When It Comes To Climate Change Stocks

In a report published Wednesday, Wedbush analyst David L. Rose downgraded Xylem (NYSE: XYL) from Outperform to Neutral, and lowered the price target from $32.00 to $27.00.

In the report, Wedbush noted, “We are lowering our rating on Xylem, Inc. to NEUTRAL from OUTPERFORM and removing the shares from the BIL (added on 12/13/2011 at $23.85) as we believe the company faces greater-than-expected margin headwinds amid more challenging end markets. In our view, the shares are likely to be range-bound until the company can demonstrate a more sustainable margin and growth trajectory. While the company's 2Q13 top-line results were generally in line with our expectations, the reduced revenue and margin outlook is troubling, suggesting management's near-term visibility has been impaired by volatility in end markets. Adjusted EPS was $0.36 versus consensus estimate of $0.44 (WS $0.47). Recent realignment actions to take out $30 million in costs are now likely to be muted by the worsening trends in Europe.”

Xylem closed on Tuesday at $25.54.

Latest Ratings for XYL

Nov 2016Boenning & ScattergoodDowngradesOutperformNeutral
Nov 2016Northcoast ResearchInitiates Coverage OnBuy
Nov 2016Janney CapitalUpgradesNeutralBuy

View More Analyst Ratings for XYL
View the Latest Analyst Ratings

Posted-In: David L. Rose WedbushAnalyst Color Downgrades Analyst Ratings


Related Articles (XYL)

View Comments and Join the Discussion!